Youjun Zhou

1.2k total citations
43 papers, 1.1k citations indexed

About

Youjun Zhou is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Youjun Zhou has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 18 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Youjun Zhou's work include Synthesis and biological activity (13 papers), Synthesis and Biological Evaluation (12 papers) and Antifungal resistance and susceptibility (7 papers). Youjun Zhou is often cited by papers focused on Synthesis and biological activity (13 papers), Synthesis and Biological Evaluation (12 papers) and Antifungal resistance and susceptibility (7 papers). Youjun Zhou collaborates with scholars based in China, Poland and Japan. Youjun Zhou's co-authors include Jü Zhu, Jiaguo Lü, Yunlong Song, Haitao Ji, Wannian Zhang, Canhui Zheng, Jie Zhu, Min Zhang, Chunquan Sheng and Jü Zhu and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

Youjun Zhou

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youjun Zhou China 17 542 420 271 150 146 43 1.1k
Haihong Huang China 18 391 0.7× 593 1.4× 369 1.4× 105 0.7× 191 1.3× 68 1.1k
Yunlong Song China 19 467 0.9× 469 1.1× 237 0.9× 173 1.2× 154 1.1× 43 1.2k
K. Raja Reddy United States 17 472 0.9× 483 1.1× 219 0.8× 94 0.6× 161 1.1× 26 1.1k
Mallika Alvala India 25 689 1.3× 766 1.8× 104 0.4× 136 0.9× 101 0.7× 68 1.6k
Tomohiko Kawate Japan 21 535 1.0× 1.1k 2.6× 344 1.3× 90 0.6× 213 1.5× 39 1.6k
Larry L. Klein United States 22 583 1.1× 367 0.9× 228 0.8× 172 1.1× 190 1.3× 59 1.2k
Christian Lherbet France 24 870 1.6× 664 1.6× 369 1.4× 132 0.9× 104 0.7× 77 1.5k
Keith Biggadike United Kingdom 19 605 1.1× 621 1.5× 305 1.1× 108 0.7× 122 0.8× 45 1.4k
David Waterson Switzerland 20 523 1.0× 393 0.9× 129 0.5× 62 0.4× 110 0.8× 38 1.2k
Serge H. Boyer United States 18 424 0.8× 473 1.1× 214 0.8× 160 1.1× 245 1.7× 28 1.2k

Countries citing papers authored by Youjun Zhou

Since Specialization
Citations

This map shows the geographic impact of Youjun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youjun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youjun Zhou more than expected).

Fields of papers citing papers by Youjun Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youjun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youjun Zhou. The network helps show where Youjun Zhou may publish in the future.

Co-authorship network of co-authors of Youjun Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Youjun Zhou. A scholar is included among the top collaborators of Youjun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youjun Zhou. Youjun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Chao, Yun Wang, Shuting Wang, et al.. (2021). Upregulation of CENPM facilitates lung adenocarcinoma progression via PI3K/AKT/mTOR signaling pathway. Acta Biochimica et Biophysica Sinica. 54(1). 99–112. 6 indexed citations
3.
Zhu, Jü, et al.. (2019). Synthesis and biological evaluation of 7-methoxy-1-(3,4,5-trimethoxyphenyl)-4,5-dihydro-2H-benzo[e]indazoles as new colchicine site inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(18). 2632–2634. 12 indexed citations
4.
Tian, Wei, Chongqing Wang, Chao Yang, et al.. (2016). Design, synthesis, and activity evaluation of selective inhibitors of anti-apoptotic Bcl-2 proteins: The effects on the selectivity of the P1 pockets in the active sites. Bioorganic & Medicinal Chemistry Letters. 26(21). 5207–5211. 6 indexed citations
5.
Zhao, Juntao, Wei Tian, Diya Lv, et al.. (2014). Design and synthesis of phenylisoxazole derivatives as novel human acrosin inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(13). 2802–2806. 3 indexed citations
6.
Zheng, Canhui, Meng Zhang, Hui Chen, et al.. (2014). Luteolin from Flos Chrysanthemi and its derivatives: New small molecule Bcl-2 protein inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(19). 4672–4677. 15 indexed citations
7.
Tian, Wei, Jü Zhu, Qianqian Chen, et al.. (2013). Synthesis and acrosin inhibitory activities of 5-phenyl-1H-pyrazole-3-carboxylic acid amide derivatives. Bioorganic & Medicinal Chemistry Letters. 23(14). 4177–4184. 9 indexed citations
8.
Chen, Qianqian, Wei Tian, Canhui Zheng, et al.. (2012). Design and synthesis of novel benzoheterocyclic derivatives as human acrosin inhibitors by scaffold hopping. European Journal of Medicinal Chemistry. 59. 176–182. 13 indexed citations
9.
Liu, Xuefei, Qianqian Chen, Jü Zhu, et al.. (2012). Synthesis and acrosin inhibitory activity of methyl 5-substituted-1H-benzo[d]imidazol-2-yl carbamate derivatives. Bioorganic & Medicinal Chemistry Letters. 22(10). 3554–3559. 2 indexed citations
10.
Zhao, Juntao, et al.. (2012). Ethyl 5-(4-aminophenyl)isoxazole-3-carboxylate. Acta Crystallographica Section E Structure Reports Online. 68(4). o1111–o1111. 3 indexed citations
11.
Liu, Xuefei, Guoqiang Dong, Jue Zhang, et al.. (2011). Discovery of novel human acrosin inhibitors by virtual screening. Journal of Computer-Aided Molecular Design. 25(10). 977–985. 9 indexed citations
12.
Zhu, Jü, et al.. (2011). Synthesis and acrosin inhibitory activities of substituted ethyl 5-(4-aminophenyl)-1H-pyrazole-3-carboxylate derivatives. Bioorganic & Medicinal Chemistry Letters. 21(19). 5822–5825. 8 indexed citations
14.
Cao, Yongbing, Youjun Zhou, Yi Xu, et al.. (2010). Transcriptional response of Candida albicans biofilms following exposure to 2-amino-nonyl-6-methoxyl-tetralin muriate. Acta Pharmacologica Sinica. 31(5). 616–628. 9 indexed citations
15.
Tang, Hui, Canhui Zheng, Juan Wu, et al.. (2009). Synthesis and antifungal activities in vitro of novel pyrazino [2,1-a] isoquinolin derivatives. Bioorganic & Medicinal Chemistry Letters. 20(3). 979–982. 25 indexed citations
16.
Ji, Haitao, Youjun Zhou, Jü Zhu, et al.. (2007). Synthesis and Antifungal Activities of Novel 2-Aminotetralin Derivatives. Journal of Medicinal Chemistry. 50(22). 5293–5300. 50 indexed citations
17.
Yao, Bin, Youjun Zhou, Jü Zhu, et al.. (2006). Design, Synthesis and Biological Evaluation of Non-azole Inhibitors of Lanosterol 14α-Demethylase of Fungi. Chinese Chemical Letters. 17(9). 1189–1192. 1 indexed citations
18.
Zhu, Jü, Jiaguo Lü, Youjun Zhou, et al.. (2006). Design, synthesis, and antifungal activities in vitro of novel tetrahydroisoquinoline compounds based on the structure of lanosterol 14α-demethylase (CYP51) of fungi. Bioorganic & Medicinal Chemistry Letters. 16(20). 5285–5289. 42 indexed citations
19.
Sheng, Chunquan, Wannian Zhang, Min Zhang, et al.. (2006). 3D-QSAR and molecular docking studies on benzothiazole derivatives as Candida albicans N-myristoyltransferase inhibitors. European Journal of Medicinal Chemistry. 42(4). 477–486. 25 indexed citations
20.
Sheng, Chunquan, Wannian Zhang, Min Zhang, et al.. (2004). Homology Modeling of Lanosterol 14α-Demethylase ofCandida albicansandAspergillus fumigatusand Insights into the Enzyme-Substrate Interactions. Journal of Biomolecular Structure and Dynamics. 22(1). 91–99. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026